EXPRESSION OF TIE RECEPTOR TYROSINE KINASE IN LEUKEMIA-CELL LINES

被引:0
|
作者
ARMSTRONG, E
KORHONEN, J
SILVENNOINEN, O
CLEVELAND, JL
LIEBERMAN, MA
ALITALO, R
机构
[1] UNIV HELSINKI, TRANSPLANTAT LAB, POB 21, HAARTMANINKATU 3, SF-00014 HEELSINKI, FINLAND
[2] UNIV HELSINKI, DEPT PATHOL, MOLEC CANC BIOL LAB, SF-00014 HELSINKI, FINLAND
[3] ST JUDE CHILDRENS RES HOSP, DEPT BIOCHEM, MEMPHIS, TN 38101 USA
[4] UNIV CINCINNATI, MED CTR, DEPT MOLEC GENET, CINCINNATI, OH 45267 USA
[5] UNIV CINCINNATI, MED CTR, DEPT BIOCHEM & MICROBIOL, CINCINNATI, OH 45267 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tie receptor tyrosine kinase mRNA was originally identified as an amplified product in reverse transcription-polymerase chain reaction analysis of human K562 leukemia cell RNA. In situ hybridization analysis revealed that the corresponding mouse gene is expressed predominantly in endothelial cells. We have explored tie mRNA and protein expression in tumor cell lines. The 4.4 kb tie mRNA was expressed at high levels in five of five human megakaryoblastic leukemia cell lines studied and in two IL-3-dependent mouse myeloid leukemia cell lines, but not in 42 other leukemia cell lines representing various hematopoietic lineages. Increased expression of tie mRNA and protein was observed upon treatment of the megakaryoblastic leukemia cells with the tumor promoter 12-0-tetradecanoyl-phorbol-13-acetate (TPA), known to enhance megakaryoblastic markers. Among several cell lines from solid tumors, two fibrosarcomas, one rhabdomyosarcoma and one melanoma cell line were positive for tie mRNA. These results suggest that among hematopoietic lineages tie is predominantly expressed in cells with megakaryoblastic properties and that the tie tyrosine kinase is a receptor for a regulatory factor specific tor megakaryoblasts, endothelial cells, and occasional tumor cell lines derived from mesenchymal tissues.
引用
收藏
页码:1585 / 1591
页数:7
相关论文
共 50 条
  • [41] ANTITUMORAL ACTIVITY OF ALKYLPHOSPHOCHOLINES AND ANALOGS IN HUMAN LEUKEMIA-CELL LINES
    UNGER, C
    FLEER, EAM
    KOTTING, J
    NEUMULLER, W
    EIBL, H
    PROGRESS IN EXPERIMENTAL TUMOR RESEARCH, 1992, 34 : 25 - 32
  • [42] FACTOR-DEPENDENT HUMAN LEUKEMIA-CELL LINES - NEW MODELS FOR REGULATION OF ACUTE NONLYMPHOCYTIC LEUKEMIA-CELL GROWTH AND DIFFERENTIATION
    OVAL, J
    TAETLE, R
    BLOOD REVIEWS, 1990, 4 (04) : 270 - 279
  • [43] LEUKEMIA-CELL LINES - IN-VITRO MODELS FOR THE STUDY OF ACUTE PROMYELOCYTIC LEUKEMIA
    DREXLER, HG
    QUENTMEIER, H
    MACLEOD, RAF
    UPHOFF, CC
    HU, ZB
    LEUKEMIA RESEARCH, 1995, 19 (10) : 681 - 691
  • [44] Expression of Tie receptor tyrosine kinase in hematopoietic cells from human umbilical cord blood.
    Li, ZH
    Grigsby, S
    Yung, YP
    Ge, Y
    Yanagihara, D
    Hu, S
    Brankow, D
    Ratzkin, BJ
    Broxmeyer, HE
    Lu, L
    BLOOD, 1995, 86 (10) : 2671 - 2671
  • [45] ESTABLISHMENT OF LEUKEMIA-CELL LINES AND THEIR SIGNIFICANCE FOR CLINICAL AND EXPERIMENTAL ONCOLOGY
    SCHNEIDER, U
    SCHWENK, HU
    HERZOG, KH
    KLINISCHE PADIATRIE, 1979, 191 (02): : 189 - 196
  • [46] EFFECTS OF RECEPTOR TYROSINE KINASE INHIBITORS ON HODGKIN LYMPHOMA DERIVED CELL LINES
    Holz, M. S.
    Janning, A.
    Renne, C.
    Brauninger, A.
    HAEMATOLOGICA, 2010, 95 : S3 - S3
  • [47] ENHANCED EXPRESSION OF THE TIE RECEPTOR TYROSINE KINASE MESSENGER-RNA IN THE VASCULAR ENDOTHELIUM OF METASTATIC MELANOMAS
    KAIPAINEN, A
    VLAYKOVA, T
    HATVA, E
    BOHLING, T
    JEKUNEN, A
    PYRHONEN, S
    ALITALO, K
    CANCER RESEARCH, 1994, 54 (24) : 6571 - 6577
  • [48] UNIQUENESS OF DEOXYNUCLEOTIDE METABOLISM IN HUMAN T LEUKEMIA-CELL LINES
    CARSON, DA
    KAYE, J
    MATSUMOTO, S
    SEEGMILLER, JE
    THOMPSON, L
    CLINICAL RESEARCH, 1979, 27 (02): : A519 - A519
  • [49] Tyrosine kinase receptor expression in thymomas
    John D. Henley
    Oscar W. Cummings
    Patrick J. Loehrer, Sr.
    Journal of Cancer Research and Clinical Oncology, 2004, 130 : 222 - 224
  • [50] Tyrosine kinase receptor expression in thymomas
    Henley, JD
    Cummings, OW
    Loehrer, PJ
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (04) : 222 - 224